Healthcare -
Biotechnology - NASDAQ - US
$ 0.27
0.334 %
$ 19.6 M
Market Cap
-0.36
P/E
INAB - OPERATING EXPENSES
Operating Expenses INAB - IN8bio, Inc.
30.3 M
LAST VALUE
43.89%
2 YEAR CAGR
72.19%
5 YEAR CAGR
0.00%
10 YEAR CAGR